Regulation of Breast Cancer Cell Motility by Insulin Receptor Substrate-2 (IRS-2) in Metastatic Variants of Human Breast Cancer Cell Lines

Oncogene - United Kingdom
doi 10.1038/sj.onc.1204920
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Novel Insulin Receptor Substrate 1 and 2 Variants in Breast and Colorectal Cancer

Oncology Reports
MedicineCancer ResearchOncology
2013English

Differential Roles of Insulin Receptor Substrate-1 and -2 (IRS-1, IRS-2) in Insulin-Like Growth Factor Signaling in Breast Cancer Cells

2003English

Overexpression of COX-2 in Celecoxib-Resistant Breast Cancer Cell Lines

Journal of Surgical Research
Surgery
2010English

Profiling the Roles of Insulin Receptor Substrate Isoforms 1 and 2 in Breast Cancer

2009English

Insulin Receptor Substrate-1 (IRS-1) and IRS-2 Expression Levels Are Associated With Prognosis in Non-Small Cell Lung Cancer (NSCLC)

PLoS ONE
Multidisciplinary
2019English

Volatile Metabolomic Signature of Human Breast Cancer Cell Lines

Scientific Reports
Multidisciplinary
2017English

Microenvironment Promotes Tumor Cell Reprogramming in Human Breast Cancer Cell Lines

PLoS ONE
Multidisciplinary
2013English

Hemimethylation Patterns in Breast Cancer Cell Lines

Cancer Informatics
Cancer ResearchOncology
2019English

Mechanism of Cell Cycle Regulation by FIP200 in Human Breast Cancer Cells

Cancer Research
Cancer ResearchOncology
2005English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy